Since PYCR1 is overexpressed in breast cancer, prostate cancer, and lung cancer cells [63,93,94], the silencing of PYCR1 expression could represent approach for cancer treatment [63,93,95]. This evidence concerns the gene PYCR1 and lung carcinoma.